Wikidata entity: Q190875
C₂₁H₃₀O₅ (P274)
Quantities
| P4250 | defined daily dose | 30 |
| P2067 | mass | 362.209 |
| P2101 | melting point | 212.5 |
| P2101 | melting point | 214 |
| P3780 | active ingredient in | ... | Q29006346 (Plenadren) | Plenadren |
| P3780 | active ingredient in | ... | Q47521406 (Cortef) | Cortef |
| P3780 | active ingredient in | ... | Q47521407 (Cortenema) | Cortenema |
| P3780 | active ingredient in | ... | Q47521408 (Cortifoam) | Cortifoam |
| P3780 | active ingredient in | ... | Q47521684 (Proctozone HC) | Proctozone HC |
| P3780 | active ingredient in | ... | Q47521778 (Locoid) | Locoid |
| P3780 | active ingredient in | ... | Q47521834 (MiCort-HC) | MiCort-HC |
| P3780 | active ingredient in | ... | Q47521961 (Pandel) | Pandel |
| P3780 | active ingredient in | ... | Q47522031 (Proctocream) | Proctocream |
| P3780 | active ingredient in | ... | Q47522139 (Solu-Cortef) | Solu-Cortef |
| P3780 | active ingredient in | ... | Q47522197 (Texacort) | Texacort |
| P3780 | active ingredient in | ... | Q47522246 (U-Cort) | U-Cort |
| P3780 | active ingredient in | ... | Q47522314 (Westcort) | Westcort |
| P3780 | active ingredient in | ... | Q48826054 (Recort Plus) | Recort Plus |
| P3780 | active ingredient in | ... | Q48826059 (Kera-HC) | Kera-HC |
| P3780 | active ingredient in | ... | Q48826116 (Cortaid) | Cortaid |
| P3780 | active ingredient in | ... | Q48826207 (Hydroskin) | Hydroskin |
| P3780 | active ingredient in | ... | Q48826227 (Proctocort) | Proctocort |
| P3780 | active ingredient in | ... | Q48826260 (Coraz) | Coraz |
| P3780 | active ingredient in | ... | Q48826324 (Caldecort) | Caldecort |
| P3780 | active ingredient in | ... | Q48826366 (Anusol HC) | Anusol HC |
| P3780 | active ingredient in | ... | Q48826426 (Colocort) | Colocort |
| P3780 | active ingredient in | ... | Q48826446 (Nucort) | Nucort |
| P3780 | active ingredient in | ... | Q48826498 (Aveeno Hydrocortisone Anti-Itch) | Aveeno Hydrocortisone Anti-Itch |
| P3780 | active ingredient in | ... | Q48828039 (Carmol HC) | Carmol HC |
| P3780 | active ingredient in | ... | Q48828052 (Preparation H Hydrocortisone) | Preparation H Hydrocortisone |
| P3780 | active ingredient in | ... | Q48828066 (Cortizone) | Cortizone |
| P3780 | active ingredient in | ... | Q48828115 (Procto-Kit) | Procto-Kit |
| P3780 | active ingredient in | ... | Q48828213 (Ala-Scalp) | Ala-Scalp |
| P3780 | active ingredient in | ... | Q48828271 (Dermacort) | Dermacort |
| P3780 | active ingredient in | ... | Q48828316 (Maximum-H) | Maximum-H |
| P3780 | active ingredient in | ... | Q48828801 (A-Hydrocort) | A-Hydrocort |
| P3780 | active ingredient in | ... | Q48828841 (Dermasorb HC) | Dermasorb HC |
| P3780 | active ingredient in | ... | Q48828858 (Dermarest Dricort) | Dermarest Dricort |
| P3780 | active ingredient in | ... | Q48828881 (Psoriasin Itch) | Psoriasin Itch |
| P3780 | active ingredient in | ... | Q48828916 (Proctosol) | Proctosol |
| P3780 | active ingredient in | ... | Q48828940 (Ala-Cort) | Ala-Cort |
| P3780 | active ingredient in | ... | Q48828964 (Blue-Emu Anti-Itch) | Blue-Emu Anti-Itch |
| P3780 | active ingredient in | ... | Q48829025 (Procto-Pak) | Procto-Pak |
| P3780 | active ingredient in | ... | Q48829075 (Pediaderm HC) | Pediaderm HC |
| P3780 | active ingredient in | ... | Q48829106 (Procto-Med) | Procto-Med |
| P3780 | active ingredient in | ... | Q48829163 (Gynecort) | Gynecort |
| P3780 | active ingredient in | ... | Q48829214 (Neosporin Eczema) | Neosporin Eczema |
| P3780 | active ingredient in | ... | Q48829326 (Scalacort) | Scalacort |
| P3780 | active ingredient in | ... | Q48829349 (Dermtex HC) | Dermtex HC |
| P233 | canonical SMILES | String | CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O | ??? |
| P373 | Commons category | String | Cortisol | ??? |
| P1343 | described by source | ... | Q124737633 (Armenian Soviet Encyclopedia, vol. 6) | Armenian Soviet Encyclopedia, vol. 6 |
| P703 | found in taxon | ... | Q83310 (house mouse) | house mouse |
| P703 | found in taxon | ... | Q15978631 (Homo sapiens) | Homo sapiens |
| P703 | found in taxon | ... | Q103810909 (Ganoderma boninense) | Ganoderma boninense |
| P703 | found in taxon | ... | Q51077617 (Phlomoides rotata) | Phlomoides rotata |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P1552 | has characteristic | ... | Q12049141 (Reichstein's compound) | Reichstein's compound |
| P527 | has part(s) | ... | Q556 (hydrogen) | hydrogen |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Cortisol-3D-balls.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O | ??? |
| P1987 | MCN code | String | 2937.21.20 | ??? |
| P2175 | medical condition treated | ... | Q1477 (ulcerative colitis) | ulcerative colitis |
| P2175 | medical condition treated | ... | Q41478 (hemorrhoid) | hemorrhoid |
| P2175 | medical condition treated | ... | Q101991 (inflammation) | inflammation |
| P2175 | medical condition treated | ... | Q826759 (status asthmaticus) | status asthmaticus |
| P2175 | medical condition treated | ... | Q52844 (enthesopathy) | enthesopathy |
| P2175 | medical condition treated | ... | Q1633590 (pruritus ani) | pruritus ani |
| P2175 | medical condition treated | ... | Q2200381 (neurogenic shock) | neurogenic shock |
| P2175 | medical condition treated | ... | Q4127186 (congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency) | congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency |
| P2175 | medical condition treated | ... | Q18553874 (adrenal cortical hypofunction) | adrenal cortical hypofunction |
| P2175 | medical condition treated | ... | Q18555301 (facial dermatosis) | facial dermatosis |
| P2175 | medical condition treated | ... | Q18555302 (scalp dermatosis) | scalp dermatosis |
| P2175 | medical condition treated | ... | Q18555307 (leg dermatosis) | leg dermatosis |
| P2175 | medical condition treated | ... | Q18555313 (hand dermatosis) | hand dermatosis |
| P2175 | medical condition treated | ... | Q56013686 (pituitary deficiency) | pituitary deficiency |
| P2175 | medical condition treated | ... | Q56013688 (chronic primary adrenal insufficiency) | chronic primary adrenal insufficiency |
| P361 | part of | ... | Q14864115 (cortisol secretion) | cortisol secretion |
| P361 | part of | ... | Q14904979 (cortisol biosynthetic process) | cortisol biosynthetic process |
| P361 | part of | ... | Q21118595 (cellular response to cortisol stimulus) | cellular response to cortisol stimulus |
| P361 | part of | ... | Q21118616 (response to cortisol) | response to cortisol |
| P361 | part of | ... | Q21468664 (cortisol metabolic process) | cortisol metabolic process |
| P361 | part of | ... | Q22243248 (cortisol receptor activity) | cortisol receptor activity |
| P361 | part of | ... | Q22313541 (cortisol binding) | cortisol binding |
| P361 | part of | ... | Q22321087 (cortisol sulfotransferase activity) | cortisol sulfotransferase activity |
| P361 | part of | ... | Q22323603 (cortisol O-acetyltransferase activity) | cortisol O-acetyltransferase activity |
| P361 | part of | ... | Q42896075 (cortisol dehydrogenase activity) | cortisol dehydrogenase activity |
| P2959 | permanent duplicated item | ... | Q26981430 (hydrocortisone) | hydrocortisone |
| P129 | physically interacts with | ... | Q2663095 (Nuclear receptor subfamily 3 group C member 1) | Nuclear receptor subfamily 3 group C member 1 |
| P129 | physically interacts with | ... | Q3454531 (Nuclear receptor subfamily 3 group C member 2) | Nuclear receptor subfamily 3 group C member 2 |
| P3489 | pregnancy category | ... | Q3679189 (Australian pregnancy category A) | Australian pregnancy category A |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q420054 (topical medication) | topical medication |
| P636 | route of administration | ... | Q1369403 (intravenous injection) | intravenous injection |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q419892 (rectal administration) | rectal administration |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q425289 (chlorthalidone) | chlorthalidone |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P3364 | stereoisomer of | ... | Q63409214 ((8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one) | (8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one |
| P3364 | stereoisomer of | ... | Q27167159 ((8S,9S,10R,11S,13S,14R,17R)-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one) | (8S,9S,10R,11S,13S,14R,17R)-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one |
| P9989 | stylized name | String | Solu-CORTEF | ??? |
| P279 | subclass of | ... | Q177911 (steroid) | steroid |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q422137 (steroid hormone) | steroid hormone |
| P2868 | subject has role | ... | Q581996 (anti-inflammatory agent) | anti-inflammatory agent |
| P2868 | subject has role | ... | Q422549 (glucocorticoid) | glucocorticoid |
| P2868 | subject has role | ... | Q3333419 (primary metabolite) | primary metabolite |
| P2868 | subject has role | ... | Q7447768 (selective glucocorticoid receptor agonist) | selective glucocorticoid receptor agonist |
| P2868 | subject has role | ... | Q16909071 (5-lipoxygenase inhibitor) | 5-lipoxygenase inhibitor |
| P910 | topic's main category | ... | Q15830650 (Category:Cortisol) | Category:Cortisol |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | hydrocortisone | ??? |
Why not click here or view trends?
log id: 5802830